Insider · CIK 0001507650

Zanganeh Mahkam

Reports to the SEC for 3 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001507650

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+3.81M sh	$13.12	+$50M	573,883,879
2026-06-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-06-11	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+14.5K sh	—	—	14,504
2026-06-04	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+100K sh	$14.60	+$1.46M	25,824,474
2026-01-02	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+11.2K sh	$8.76	+$98.4K	11,232
2025-10-21	SMMTSummit Therapeutics Inc.A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+267K sh	$18.74	+$5M	25,724,474
2025-10-21	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+26.7K sh	$18.74	+$500K	76,680
2025-10-21	SMMTSummit Therapeutics Inc.A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+14M sh	$18.74	+$262M	570,073,879
2025-09-11	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$18.07	+$90.4K	556,093,090
2025-09-10	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+333K sh	$17.68	+$5.89M	556,088,090
2025-08-15	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-08-15	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+24.1K sh	—	—	24,134
2025-05-30	SMMTSummit Therapeutics Inc.M Exercise/Conversion	Director, Co-Chief Executive Officer, 10% Owner	MExercise/Conversion	+74.5K sh	$2.64	+$197K	555,754,696
2025-05-30	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, Co-Chief Executive Officer, 10% Owner	MExercise/Conversion	−74.5K sh	—	—	0
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+1.04M sh	—	—	1,040,000
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+400K sh	—	—	400,000
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+9.59M sh	—	—	9,590,558
2025-04-08	SMMTSummit Therapeutics Inc.X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+3.99M sh	$1.58	+$6.3M	555,680,151
2025-04-08	SMMTSummit Therapeutics Inc. · Warrant (right to buy)X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+3.99M sh	—	—	0
2025-02-03	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director	XExercise of In-Money	+30.1K sh	$11.00	+$331K	725,395
2025-02-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−30.1K sh	—	—	0
2025-01-24	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director	XExercise of In-Money	+30.1K sh	$11.00	+$331K	695,274
2025-01-24	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−30.1K sh	—	—	0
2025-01-02	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+10.7K sh	$9.18	+$98.4K	10,724
2024-10-03	SMMTSummit Therapeutics Inc.X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+316K sh	$1.58	+$499K	10,199,776
2024-10-03	SMMTSummit Therapeutics Inc. · Warrant (right to buy)X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	−316K sh	—	—	0
2024-09-11	SMMTSummit Therapeutics Inc.A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+44.1K sh	$22.70	+$1M	24,967,852
2024-08-23	SMMTSummit Therapeutics Inc. · Performance Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+260K sh	—	—	260,000
2024-08-23	SMMTSummit Therapeutics Inc. · Performance Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+100K sh	—	—	100,000
2024-08-23	SMMTSummit Therapeutics Inc. · Performance Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+2.4M sh	—	—	2,397,640
2024-08-09	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+200K sh	—	—	200,000
2024-07-03	PLSEPULSE BIOSCIENCES, INC.X Exercise of In-Money	Director	XExercise of In-Money	+60.2K sh	—	—	665,153
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director	PPurchase	+30.1K sh	—	—	30,121
2024-07-03	PLSEPULSE BIOSCIENCES, INC. · Warrant (right to buy)P Purchase	Director	PPurchase	+30.1K sh	—	—	30,121
2024-06-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-06-06	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+8,247 sh	—	—	8,247
2024-03-27	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+26K sh	$3.72	+$96.7K	520,814
2024-03-27	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+34.3K sh	$3.72	+$128K	24,923,800
2024-03-27	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+20K sh	$3.71	+$74.2K	50,000
2024-03-26	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+30K sh	$3.75	+$113K	30,000
2023-12-12	SMMTSummit Therapeutics Inc.P Purchase	Director, Co-Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$2.07	+$10.4K	494,814
2023-12-11	SMMTSummit Therapeutics Inc.X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+490K sh	$1.44	+$705K	489,814
2023-12-11	SMMTSummit Therapeutics Inc.X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	+316K sh	$1.58	+$499K	24,889,479
2023-12-11	SMMTSummit Therapeutics Inc. · Warrant (right to buy)X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	−490K sh	—	—	0
2023-12-11	SMMTSummit Therapeutics Inc. · Warrant (right to buy)X Exercise of In-Money	Director, Co-Chief Executive Officer, 10% Owner	XExercise of In-Money	−316K sh	—	—	0
2023-11-13	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.14	+$42.8K	548,836
2023-11-13	PLSEPULSE BIOSCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+56.1K sh	$2.14	+$120K	604,911
2023-11-13	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2023-11-13	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−56.1K sh	—	—	0
2023-10-13	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Co-Chief Executive Officer, 10% Owner	AAward	+12M sh	—	—	11,988,198

Recent filings

Accepted (ET)
Jun 154
Zanganeh Mahkam0001437749-26-020722
SEC(opens sec.gov)
Jun 124
Zanganeh Mahkam0001507650-26-000007
SEC(opens sec.gov)
Jun 44
Zanganeh Mahkam0001507650-26-000005
SEC(opens sec.gov)
Jan 64
Zanganeh Mahkam0001507650-26-000003
SEC(opens sec.gov)
Oct 234
Zanganeh Mahkam0001507650-25-000003
SEC(opens sec.gov)
Sep 114
Zanganeh Mahkam0001599298-25-000143
SEC(opens sec.gov)
Aug 194
Zanganeh Mahkam0001437749-25-027396
SEC(opens sec.gov)
Jun 24
Zanganeh Mahkam0001599298-25-000107
SEC(opens sec.gov)
May 14
Zanganeh Mahkam0001599298-25-000091
SEC(opens sec.gov)
Apr 94
Zanganeh Mahkam0001599298-25-000060
SEC(opens sec.gov)
Feb 114
Zanganeh Mahkam0001437749-25-003449
SEC(opens sec.gov)

Companies

Address

C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY

HAYWARD, CA, 94545